NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
NeuroPace, Inc. (NPCE) reported a Q3 loss of $0.19 per share, which was better than the Zacks Consensus Estimate of a $0.26 loss. This is an improvement from the $0.28 loss per share reported a year ago.
November 13, 2024 | 12:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NeuroPace, Inc. reported a Q3 loss of $0.19 per share, outperforming the Zacks Consensus Estimate of a $0.26 loss. This is an improvement from the previous year's $0.28 loss per share.
The better-than-expected earnings report, with a smaller loss than anticipated, is likely to have a positive short-term impact on NPCE's stock price. The improvement from last year's loss also suggests positive momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100